Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Antengene Announces XPOVIO® (selinexor) Approved for Its Third Indication in South Korea, Bringing Fresh Hope to Patients with MM in the Country 2024-10-18 10:35
Columbia Asia Harnesses Solar Energy for Sustainable Healthcare 2024-10-18 09:00
OmniaBio Announces Opening of New Commercial Manufacturing Facility in Canada, Bringing Life-Saving Cell and Gene Therapies to Patients 2024-10-18 07:00
Telix Files Form 20-F Registration Statement for Nasdaq ADS 2024-10-18 05:32
Press Announcement: AIMed24 Announces Strategic Partnership with Frost & Sullivan 2024-10-17 23:01
Ublives Introduces SoleFlux Relax Compression Boots: The Perfect Gift for Parents to Relieve Leg Pain 2024-10-17 22:00
Exclusive Interview with Lang Guojun, founder of Sanyou Bio: The Key to Breaking the Bottleneck of New Drug Innovation--The Past and Future of the Super-Trillion Molecule Library 2024-10-17 22:00
Chipscreen Biosciences' Innovative Anti-Tumor Drug CS231295 Tablets: Investigational New Drug (IND) Application Accepted 2024-10-17 21:38
Amplo Biotechnology Announces Three Presentations at the European Society of Gene and Cell Therapy 31st Annual Congress 2024-10-17 18:39
Telix Q3 2024 Business Update - Quarterly Revenue Exceeds AU$200M 2024-10-17 15:54
KIND Announces Late-Breaking Abstract Accepted for Presentation on AND017 Clinical Trials to Treat Anemia in Chronic Kidney Disease (CKD) at ASN - Kidney Week 2024 2024-10-17 15:44
AXA Insurance Announces Strategic Name Change of "XL Re China" to "AXA International Re" 2024-10-17 15:20
Cambrex Opens New Stability Storage Facility in Durham, North Carolina 2024-10-17 15:00
CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy 2024-10-17 14:30
Bio X Cell Announces Board of Director Appointments 2024-10-17 14:00
IND Application for a Phase Ⅲ Clinical Study of KN026 Combined with Albumin-bound Docetaxel as Neoadjuvant Treatment for Breast Cancer was Approved 2024-10-17 10:15
Innovent Announces Phase 2 Clinical Study of Picankibart (IBI112) in Chinese Patients with Ulcerative Colitis Met Primary Endpoint 2024-10-17 08:00
Presagen's AI fertility product Life Whisperer acquired by Astec 2024-10-17 03:11
Mars announces new leadership for its Veterinary Health and Science & Diagnostics businesses 2024-10-16 23:00
EmeTerm Smart and HeadaTerm 2 Achieve Health Canada MDL Certification 2024-10-16 21:30
1 18 19 20 21 22 1596